Pages that link to "Q43130050"
Jump to navigation
Jump to search
The following pages link to Generation of functional cholangiocyte-like cells from human pluripotent stem cells and HepaRG cells. (Q43130050):
Displaying 50 items.
- Directed differentiation of human induced pluripotent stem cells into functional cholangiocyte-like cells (Q33787914) (← links)
- Development and characterization of human-induced pluripotent stem cell-derived cholangiocytes (Q35661071) (← links)
- A Convenient and Efficient Method to Enrich and Maintain Highly Proliferative Human Fetal Liver Stem Cells (Q35816578) (← links)
- Novel surface markers directed against adult human gallbladder (Q35894100) (← links)
- Cross Talk Between GH-Regulated Transcription Factors HNF6 and CUX2 in Adult Mouse Liver (Q36004102) (← links)
- Hedgehog Signaling Overcomes an EZH2-Dependent Epigenetic Barrier to Promote Cholangiocyte Expansion (Q36218507) (← links)
- Transplantation of hESC-derived hepatocytes protects mice from liver injury (Q36366073) (← links)
- Bile Acid-Induced Toxicity in HepaRG Cells Recapitulates the Response in Primary Human Hepatocytes (Q36464118) (← links)
- Cholangiocytes derived from human induced pluripotent stem cells for disease modeling and drug validation (Q36621970) (← links)
- Notch Signaling Coordinates Progenitor Cell-Mediated Biliary Regeneration Following Partial Hepatectomy. (Q36661790) (← links)
- Role of β-catenin in development of bile ducts. (Q36716930) (← links)
- Cell sources for in vitro human liver cell culture models (Q37208518) (← links)
- Development of a rapid screen for the endodermal differentiation potential of human pluripotent stem cell lines (Q37428040) (← links)
- De novo HAPLN1 expression hallmarks Wnt-induced stem cell and fibrogenic networks leading to aggressive human hepatocellular carcinomas (Q37457383) (← links)
- Low-dose acetaminophen induces early disruption of cell-cell tight junctions in human hepatic cells and mouse liver (Q37612385) (← links)
- Longitudinal in vivo bioimaging of hepatocyte transcription factor activity following cholestatic liver injury in mice (Q37623548) (← links)
- Potential of human induced pluripotent stem cells in studies of liver disease (Q38287145) (← links)
- Treatment of hepatitis C in difficult-to-treat patients (Q38431523) (← links)
- Current strategies to generate mature human induced pluripotent stem cells derived cholangiocytes and future applications (Q38774569) (← links)
- Expression kinetics of hepatic progenitor markers in cellular models of human liver development recapitulating hepatocyte and biliary cell fate commitment (Q38844070) (← links)
- Efficient and Controlled Generation of 2D and 3D Bile Duct Tissue from Human Pluripotent Stem Cell-Derived Spheroids (Q38872458) (← links)
- Differentially expressed MicroRNAs provide mechanistic insight into fibrosis-associated liver carcinogenesis in mice (Q38888305) (← links)
- Pluripotent stem cells for disease modeling and drug screening: new perspectives for treatment of cystic fibrosis? (Q38932077) (← links)
- Challenges on the road to a multicellular bioartificial liver (Q39036360) (← links)
- Regenerative Medicine and the Biliary Tree (Q39136966) (← links)
- Architecture in 3D cell culture: An essential feature for in vitro toxicology (Q39213995) (← links)
- Role of ErbB/HER family of receptor tyrosine kinases in cholangiocyte biology. (Q39410914) (← links)
- Hepatic Differentiation of Human Induced Pluripotent Stem Cells in a Perfused Three-Dimensional Multicompartment Bioreactor. (Q40965254) (← links)
- Stage-specific regulation of the WNT/β-catenin pathway enhances differentiation of hESCs into hepatocytes (Q41009209) (← links)
- Footprint-free human fetal foreskin derived iPSCs: A tool for modeling hepatogenesis associated gene regulatory networks (Q41108782) (← links)
- Single-cell RNA-Seq analysis reveals dynamic trajectories during mouse liver development (Q47102009) (← links)
- Alagille syndrome: Genetics and Functional Models (Q47107627) (← links)
- Optimized light-inducible transcription in mammalian cells using Flavin Kelch-repeat F-box1/GIGANTEA and CRY2/CIB1. (Q47108913) (← links)
- Development and characterization of cholangioids from normal and diseased human cholangiocytes as an in vitro model to study primary sclerosing cholangitis (Q47690325) (← links)
- Rapid Screening of the Endodermal Differentiation Potential of Human Pluripotent Stem Cells (Q49998953) (← links)
- A single-cell transcriptomic analysis reveals precise pathways and regulatory mechanisms underlying hepatoblast differentiation (Q50433197) (← links)
- Comparison of the transcriptomic profile of hepatic human induced pluripotent stem like cells cultured in plates and in a 3D microscale dynamic environment. (Q51088952) (← links)
- Directed differentiation of cholangiocytes from human pluripotent stem cells. (Q52931552) (← links)
- [Human pluripotent stem cells and liver disorders]. (Q53085858) (← links)
- Src kinase inhibition reduces inflammatory and cytoskeletal changes in ΔF508 human cholangiocytes and improves cystic fibrosis transmembrane conductance regulator correctors efficacy. (Q53098241) (← links)
- Adenylyl cyclase 5 links changes in calcium homeostasis to cAMP-dependent cyst growth in polycystic liver disease. (Q54846617) (← links)
- Complex bile duct network formation within liver decellularized extracellular matrix hydrogels (Q57111858) (← links)
- Efficient functional cyst formation of biliary epithelial cells using microwells for potential bile duct organisation in vitro (Q57114347) (← links)
- The use of human pluripotent stem cells for modelling liver development and disease (Q57150366) (← links)
- Calcium Signaling in Cholangiocytes: Methods, Mechanisms, and Effects (Q60912697) (← links)
- Regenerative Medicine of the Bile Duct: Beyond the Myth (Q64039446) (← links)
- Clonorchis sinensis excretory-secretory products increase malignant characteristics of cholangiocarcinoma cells in three-dimensional co-culture with biliary ductal plates (Q64104197) (← links)
- Cholangiocyte pathobiology. (Q64913364) (← links)
- High-Throughput Screening for Modulators of CFTR Activity Based on Genetically Engineered Cystic Fibrosis Disease-Specific iPSCs. (Q64941005) (← links)
- Cell fate decisions of human iPSC-derived bipotential hepatoblasts depend on cell density (Q89498690) (← links)